Amperos Health vs Crosby Health
Two Denials & Appeals vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Amperos Health | Crosby Health | |
|---|---|---|
| Pricing model | Not published | Contingency (pay from recoveries) · Managed appeals; SaaS license also offered |
| Speed to go live | No configuration; working day one | Portal-based upload, light integration |
| Automation model | Autonomous agents · AI biller calls and works denials | Autonomous agents · Apollo LLM drafts and submits appeals |
| Built for | Small practices, Mid-size groups, Billing companies | Mid-size groups, Enterprise systems |
| Security posture | SOC 2 Type I, HIPAA | HIPAA |
| Company maturity | 3 yrs (est. 2023) | 4 yrs (est. 2022) |
| Financial backing | $20.2M · Series A | $2.2M+ · Seed |
| Named customers | None public | 1 named |
| Published results | Specific numbers public | Specific numbers public |
| Documented integrations | None documented | None documented |
| Third-party validation | None found | None found |
Bottom line
- Pick Amperos if denials and aging A/R are piling up and you want an AI biller chasing claims from day one with no setup project.
- Pick Crosby Health if clinical denials are piling up unworked and you want appeals generated and submitted automatically while paying only from what gets recovered.
Amperos Health
AI biller that works denials by phone and portal
- Founded
- 2023
- HQ
- New York, NY
- Stage
- Series A
- Raised
- $20.2M
What it does
- Calls payers to check status and dispute denials
- Works payer portals for claim follow-up
- Drafts and submits appeals with medical records
- Submits corrected claims
- Denial analytics and root-cause reporting
Where it's strong
- Automates the actual follow-up work, phone calls included, rather than just flagging denials for staff.
- Real volume behind the claims: over 3,000 clinical locations served and roughly $700M in annual recovered revenue across 500,000-plus claims.
- Pairs AI automation with human billing experts for complex claims instead of forcing everything through the model.
What buyers should weigh
- Founded in 2023, so it is still a young vendor for a function that touches core cash flow.
- Named reference customers are not public; ask for references in your specialty and billing system.
- Best fit is denial follow-up and recovery; it is not a full front-to-back RCM platform.
Crosby Health
AI-generated clinical appeals for denied claims
- Founded
- 2022
- HQ
- New York, NY
- Stage
- Seed
- Raised
- $2.2M+
What it does
- Generates clinical appeal letters for denied claims with AI
- Apollo clinical LLM reads up to 300 pages of documentation
- Finds medical necessity evidence inside clinical notes
- Submits appeals through one unified payer submission channel
- Tracks appeal status and payer decisions with notifications
- Supports medical coding review and chart auditing
Where it's strong
- Attacks a problem most providers simply abandon: appealing every denial, including small balances that are uneconomical to work manually.
- Unified payer submission removes the portal-and-fax maze that makes appeals so labor intensive.
- Early users report appealing denials 300% faster than manual processes.
What buyers should weigh
- Very early company: roughly 15 employees, about $3M raised, and only one publicly named customer.
- Appeals-only focus means it recovers lost revenue but does nothing to prevent denials upstream.
- No publicly documented EHR integrations, so verify how clinical documentation actually gets into the platform.
Named customers
EmpowerMe Wellness
Compare against the rest of Denials & Appeals
Deciding between these two?
First Pass tracks Denials & Appeals every week: funding, launches, and what changed since this page was written.